In vaccinated outpatients with mild COVID-19, which patients do you still prescribe nirmatrelvir-ritonavir?

Dryden-Peterson S, Kim A, Kim AY, et al. Nirmatrelvir plus ritonavir for early COVID-19 in a large U.S. health system (real-world effectiveness study). Annals of Internal Medicine. 2023–2024 analyses.